TR Einarson

1.6k total citations
38 papers, 1.1k citations indexed

About

TR Einarson is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, TR Einarson has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 6 papers in Public Health, Environmental and Occupational Health and 6 papers in Economics and Econometrics. Recurrent topics in TR Einarson's work include Maternal Mental Health During Pregnancy and Postpartum (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Pharmaceutical studies and practices (5 papers). TR Einarson is often cited by papers focused on Maternal Mental Health During Pregnancy and Postpartum (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Pharmaceutical studies and practices (5 papers). TR Einarson collaborates with scholars based in Canada, United States and Italy. TR Einarson's co-authors include Gideon Koren, Edward Keystone, Antonio Addis, Lisa Dolovich, Julie Vaillancourt, Y. Ingrid Goh, Anne Pastuszak, David J. Sahn, Preet Kaur and K. Johnson and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Annals of the Rheumatic Diseases.

In The Last Decade

TR Einarson

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
TR Einarson Canada 13 346 337 282 117 109 38 1.1k
Indra R. Gupta Canada 23 415 1.2× 152 0.5× 132 0.5× 44 0.4× 177 1.6× 60 1.7k
Fiona Mackie Australia 19 338 1.0× 197 0.6× 82 0.3× 72 0.6× 118 1.1× 53 1.3k
Rima Rozen Canada 12 343 1.0× 187 0.6× 670 2.4× 37 0.3× 101 0.9× 13 1.2k
Robert L. Andres United States 15 585 1.7× 241 0.7× 167 0.6× 21 0.2× 167 1.5× 34 1.2k
Suzanne M. Norby United States 16 153 0.4× 507 1.5× 411 1.5× 31 0.3× 49 0.4× 42 1.7k
Yongling Xiao United States 22 145 0.4× 154 0.5× 101 0.4× 63 0.5× 121 1.1× 46 1.2k
Leendert C. Paul Netherlands 30 296 0.9× 503 1.5× 54 0.2× 395 3.4× 253 2.3× 77 2.9k
A. Juarez-Garcia United Kingdom 13 290 0.8× 401 1.2× 36 0.1× 94 0.8× 400 3.7× 51 1.3k
Daniel Mines United States 20 68 0.2× 102 0.3× 134 0.5× 116 1.0× 95 0.9× 34 1.0k
Martin Tattersall Australia 19 290 0.8× 645 1.9× 74 0.3× 79 0.7× 70 0.6× 43 1.5k

Countries citing papers authored by TR Einarson

Since Specialization
Citations

This map shows the geographic impact of TR Einarson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by TR Einarson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites TR Einarson more than expected).

Fields of papers citing papers by TR Einarson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by TR Einarson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by TR Einarson. The network helps show where TR Einarson may publish in the future.

Co-authorship network of co-authors of TR Einarson

This figure shows the co-authorship network connecting the top 25 collaborators of TR Einarson. A scholar is included among the top collaborators of TR Einarson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with TR Einarson. TR Einarson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Einarson, TR, et al.. (2017). Economic Burden of Cardiovascular Disease In Type 2 Diabetes: A Systematic Review. Value in Health. 20(9). A476–A477. 9 indexed citations
2.
Acs, Annabel, et al.. (2017). Prevalence of Cardiovascular Disease In Type 2 Diabetes: A Global Systematic Review. Value in Health. 20(9). A475–A475. 8 indexed citations
3.
Einarson, TR, et al.. (2015). Economic Analysis of Ustekinumab for Psoriatic Arthritis in Russia. Value in Health. 18(7). A648–A648. 1 indexed citations
4.
Palmay, Lesley, Marion Elligsen, Sandra A N Walker, et al.. (2014). Hospital-wide Rollout of Antimicrobial Stewardship: A Stepped-Wedge Randomized Trial. Clinical Infectious Diseases. 59(6). 867–874. 39 indexed citations
5.
6.
Einarson, TR, et al.. (2008). The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events. Annals of the Rheumatic Diseases. 68(7). 1136–1145. 278 indexed citations
7.
Goh, Y. Ingrid, et al.. (2007). Prenatal Multivitamin Supplementation and Rates of Pediatric Cancers: A Meta-Analysis. Clinical Pharmacology & Therapeutics. 81(5). 685–691. 83 indexed citations
8.
Machado, Maurício de Nassau, et al.. (2006). PCN63 ADVANCED CUTANEOUS MALIGNANT MELANOMA: SYSTEMATIC REVIEW OF PHARMACOECONOMIC AND QUALITY OF LIFE STUDIES. Value in Health. 9(6). A295–A295. 1 indexed citations
9.
Iskedjian, Michaël, et al.. (2003). PNP10: COST-EFFECTIVENESS OF ATOMOXETINE IN THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS. Value in Health. 6(3). 275–275. 2 indexed citations
10.
Hemels, Martin E W, Michaël Iskedjian, N. Iscoe, Neil Fleshner, & TR Einarson. (2002). CN2 COST-UTILITY ANALYSIS OF LHRH AGONISTS IN THE TREATMENT OF METASTATIC PROSTATE CANCER. Value in Health. 5(3). 129–130. 1 indexed citations
11.
Iskedjian, Michaël, Antonio Addis, & TR Einarson. (2002). PHP18 ESTIMATING THE ECONOMIC BURDEN OF HOSPITALIZATION DUE TO PATIENT NONADHERENCE IN CANADA. Value in Health. 5(6). 470–471. 8 indexed citations
12.
Knowles, Simon R., et al.. (2001). Reporting of fatal adverse drug reactions.. PubMed. 8(2). 84–8. 15 indexed citations
13.
Addis, Antonio, Lisa Dolovich, TR Einarson, & Gideon Koren. (2000). Can we use anxiolytics during pregnancy without anxiety?. PubMed. 46. 549–51. 5 indexed citations
14.
Busto, U., et al.. (1998). Assessment of the risk of therapeutic dose benzodiazepine withdrawal reactions using meta-analysis. 5(3). 161–168. 2 indexed citations
15.
Dolovich, Lisa, et al.. (1998). Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ. 317(7162). 839–843. 196 indexed citations
16.
17.
Einarson, Adrienne, et al.. (1993). Prospective study of hydroxyzine use in pregnancy. Reproductive Toxicology. 7(6). 640–640. 2 indexed citations
18.
Jacobson, Sheila, Preet Kaur, Anne Pastuszak, et al.. (1992). Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. The Lancet. 339(8792). 530–533. 203 indexed citations
19.
Koren, Gideon, et al.. (1992). The Effects of Impaired Liver Function on the Elimination of Antineoplastic Agents. Annals of Pharmacotherapy. 26(3). 363–371. 62 indexed citations
20.
Einarson, TR, et al.. (1989). Effect of Auxiliary Prescription Labels on the Elderly Ambulatory Patient's Drug Knowledge. DICP. 23(4). 324–329. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Indra R. Gupta Breakdown of academic impact, for papers by Fiona Mackie Breakdown of academic impact, for papers by Rima Rozen Breakdown of academic impact, for papers by Robert L. Andres Breakdown of academic impact, for papers by Suzanne M. Norby Breakdown of academic impact, for papers by Yongling Xiao Breakdown of academic impact, for papers by Leendert C. Paul Breakdown of academic impact, for papers by A. Juarez-Garcia Breakdown of academic impact, for papers by Daniel Mines Breakdown of academic impact, for papers by Martin Tattersall
Rankless by CCL
2026